CE-certified flat plate centrifuge!
How does the Blovebird PB series achieve 1μm-level aseptic separation?

In the pharmaceutical industry, the cleanliness of the production environment is directly related to the safety and effectiveness of drugs. However, traditional centrifuges often become "pollution hazards" in clean workshops due to problems such as insufficient sealing performance and incomplete cleaning. A biopharmaceutical company once suffered batch contamination due to poor sealing of the centrifuge, with direct losses of up to 5 million yuan! GMP regulations clearly require that pharmaceutical equipment must meet strict airtight and aseptic standards, and the blovebird PB series flat plate closed centrifuge was born for this purpose, becoming the "invisible guard" of pharmaceutical clean workshops.

01 Fully enclosed design to eliminate contamination risks 

The blovebird PB series adopts a pharmaceutical-grade fully enclosed structure, and key parts are equipped with silicone sealing rings, which can withstand 121℃ high-temperature steam sterilization to ensure a sterile environment without leakage. The inner wall of the drum is mirror-polished (Ra≤0.8μm), and the surface is smooth without dead corners to prevent material residues from breeding bacteria. Whether it is vaccines, blood products or high-purity APIs, the PB series can provide reliable separation guarantees.

02 CIP automatic cleaning, 360° clean without dead corners 

To meet the high cleanliness requirements of the pharmaceutical industry, the PB series is equipped with a CIP automatic cleaning system. Through 360° rotating spray technology, every contact surface of the drum, inner wall and pipeline is thoroughly cleaned. The residual volume after cleaning is extremely low, which meets the FDA and GMP certification standards and greatly reduces the risk of cross contamination.

03 Authoritative certification, real cases witness the effect 

The blovebird PB series has passed the CE certification and has a number of patented technologies. After a well-known domestic vaccine company introduced the PB series, the product qualification rate increased from 91% to 99.7%, and production efficiency and product quality were optimized simultaneously.